---
layout: single
title:  "Engineering T-Cells"
categories: oncology

---
To dramatically reduce costs off-the-shelf CAR-T cells. The off-the shelf path would preempt the very costly ($500,000) , laborious and time consuming work of autologous CAR-T, produced from the patientâ€™s own cells. 
 
[Eric Topol Ground Truth](https://erictopol.substack.com/p/engineering-t-cells?utm_source=substack&utm_medium=email)